AZD3965 CAS No. 1448671-31-5
AZD3965
| Catalog # | Pkg Size | Price(USD) | Quantity | Buy this product |
|---|---|---|---|---|
| R-C-1357 | 50mg | 425.00 | + Add to cart |
|
| R-C-1357 | 100mg | 715.00 | + Add to cart |
|
| R-C-1357 | 200mg | 1190.00 | + Add to cart |
|
|
|
||||
Product description
AZD3965 is a selective inhibitor of monocarboxylate transporter 1(MCT1)with a binding affinity of 1.6 nM,is 6 fold selective over MCT2 and does not inhibit MCT4 at 10 μM.In vivo,AZD3965 is well tolerated and induces a dose and time dependent accumulation of lactate in the tumours,suppresses tumour growth and in the Raji model potentiates the effects of Rituxan,doxorubicin and bendamustine. The selective inhibition of lactate transport by the MCT1 inhibitor AZD3965 offers an novel mechanism for targeting the metabolic phenotype in tumours that preferentially express MCT1.
| Appearance | N/A |
|---|---|
| Molecular Weight | N/A |
| purity | >95% |
| PDI by GPC | <1.5 |
| Solubility | N/A |
| Storage | -20℃, protected from light and moisture |
| Transportation | 4-25℃ temperature for up to 2 weeks |
| Stability | 1 year |
Document
Related Product

Items-$0.00

Email:
Tel.:
msds---AZD3965
RuixiBiotechCo.Ltd /KamulinBiotechco.ltd
Add: Room 20F 2002, Meiyuan Building, Yanta District, Xi’ an City, Shaanxi Province 710061 China
Tel: 02988811435
Fax: (86-29)8881-1435
Email: sales@ruixibiotech.com
Web: http://www.ruixibiotech.com


